Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Feb;22(1):1-2.
doi: 10.1007/s10557-008-6079-x.

Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al."

A M S Belonje, R A de Boer, A A Voors
Editorial

Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al."

A M S Belonje et al. Cardiovasc Drugs Ther. 2008 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1111/j.1523-1755.2004.00450.x', 'is_inner': False, 'url': 'https://doi.org/10.1111/j.1523-1755.2004.00450.x'}, {'type': 'PubMed', 'value': '14871396', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14871396/'}]}
    2. Jones M, Ibels L, Schenkel B, Zagari M. Impact of epoetin alfa on clinical end points in patients with chronic renal failure: a meta-analysis. Kidney Int 2004;65:757–67. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa065485', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa065485'}, {'type': 'PubMed', 'value': '17108343', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17108343/'}]}
    2. Singh AK, Szczech L, Tang KL, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085–98. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMoa062276', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmoa062276'}, {'type': 'PubMed', 'value': '17108342', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17108342/'}]}
    2. Drueke TB, Locatelli F, Clyne N, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 2006;355:2071–84. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJMc066568', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejmc066568'}, {'type': 'PubMed', 'value': '17329707', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17329707/'}]}
    2. Pfeffer MA. An ongoing study of anemia correction in chronic kidney disease. N Engl J Med 2007;356:959–61. - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.jacc.2006.11.024', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.jacc.2006.11.024'}, {'type': 'PubMed', 'value': '17306703', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/17306703/'}]}
    2. Ponikowski P, Anker SD, Szachniewicz J, et al. Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2007;49:753–62. - PubMed

MeSH terms